quinazolines has been researched along with d-alpha tocopherol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dvorák, J; Hyspler, R; Kalábová, H; Kasparová, M; Krcmová, L; Melichar, B; Solichová, D; Urbánek, L | 1 |
Bachawal, SV; Sylvester, PW; Wali, VB | 2 |
Huo, ZJ; Liu, K; Liu, P; Pang, B; Wang, SJ; Wang, ZQ; Zuo, WS | 1 |
Chen, JN; Chen, SY; Lin, PS; Liu, HC; Wei, CW; Yiang, GT | 1 |
5 other study(ies) available for quinazolines and d-alpha tocopherol
Article | Year |
---|---|
Intestinal permeability, vitamin A absorption and serum alpha-tocopherol during therapy with gefitinib.
Topics: Adult; Aged; alpha-Tocopherol; Case-Control Studies; Female; Gefitinib; Humans; Intestinal Absorption; Intestines; Male; Middle Aged; Permeability; Quinazolines; Vitamin A | 2010 |
Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Culture Media, Serum-Free; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Mammary Neoplasms, Animal; Mice; Quinazolines; Signal Transduction; Trastuzumab; Vitamin E | 2010 |
Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Proliferation; Chromans; Erlotinib Hydrochloride; Female; Gefitinib; Mammary Neoplasms, Animal; Mice; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; STAT Transcription Factors; Vitamin E | 2010 |
Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Female; Humans; Lactic Acid; Lapatinib; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mononuclear Phagocyte System; Nanoparticles; Phagocytosis; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinazolines; Tumor Burden; Vitamin E; Xenograft Model Antitumor Assays | 2015 |
Combined treatment with vitamin E and gefitinib has synergistic effects to inhibit TGF-β1-induced renal fibroblast proliferation.
Topics: Animals; Cell Line; Cell Proliferation; Drug Synergism; Fibroblasts; Gefitinib; Gene Expression Regulation; Kidney; MAP Kinase Signaling System; Quinazolines; Rats; Transforming Growth Factor beta1; Vitamin E | 2016 |